1. Bell ET (1952) Hyalinization of the islets of Langerhans in diabetes mellitus. Diabetes 1:341–344
2. Berends MJH, Nieuwenhuis MG, Lips CJM, Blok APR, Ooms ECM, Veldhuizen RWA (1990) A comparative study between human B-cell insulin and islet amyloid polypeptide (IAPP) storage and amyloid deposition in type 2 diabetes mellitus and in non-diabetics. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P (eds) Amyloid and amyloidosis 1990. Kluwer, Dordrecht, pp 457–461
3. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR, Turner RC (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151–159
4. Clark A, Saad MF, Nezzer T, Uren C, Knowler WC, Bennett PH, Turner RC (1990) Islet amyloid polypeptide in diabetic and non-diabetic Pima Indiens. Diabetologia 33:285–289
5. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628–8632